ezetimibe has been researched along with Pregnancy in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Banach, M; Lewek, J | 1 |
Anderson, TJ; Barry, AR; Couture, P; Dayan, N; Francis, GA; Genest, J; Grégoire, J; Grover, SA; Gupta, M; Hegele, RA; Lau, D; Leiter, LA; Leung, AA; Lonn, E; Mancini, GBJ; Manjoo, P; McPherson, R; Ngui, D; Pearson, GJ; Piché, ME; Poirier, P; Sievenpiper, J; Stone, J; Thanassoulis, G; Ward, R; Wray, W | 1 |
Doyle, M; Moss, S; Rees, D; Tardo, D | 1 |
Naoumova, RP; Soutar, AK; Thompson, GR | 1 |
3 review(s) available for ezetimibe and Pregnancy
Article | Year |
---|---|
Dyslipidemia Management in Pregnancy: Why Is It not Covered in the Guidelines?
Topics: Animals; Anticholesteremic Agents; Cholesterol, LDL; Dyslipidemias; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications; Proprotein Convertase 9 | 2022 |
Current management of severe homozygous hypercholesterolaemias.
Topics: Adolescent; Adult; Apolipoproteins B; Azetidines; Blood Component Removal; Child; Cholesterol; Coronary Disease; Ezetimibe; Female; Genes, Recessive; Genetic Therapy; Homozygote; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipid Metabolism; Liver Transplantation; Male; Models, Genetic; Mutation; Pregnancy; Time Factors | 2004 |
Drugs for lipids.
Topics: Anticholesteremic Agents; Apolipoproteins; Azetidines; Bile Acids and Salts; Cholesterol; Cholesterol, LDL; Clofibric Acid; Drug Interactions; Ezetimibe; Female; Fish Oils; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Niacin; Pregnancy; Triglycerides | 2005 |
2 other study(ies) available for ezetimibe and Pregnancy
Article | Year |
---|---|
2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults.
Topics: Adult; Apolipoproteins B; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Dietary Supplements; Dyslipidemias; Eicosapentaenoic Acid; Ezetimibe; Female; Health Behavior; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; PCSK9 Inhibitors; Pregnancy; Pregnancy Complications; Primary Prevention; Risk Assessment; Secondary Prevention | 2021 |
Complex disease management of pregnant young patient with familial hypercholesterolaemia complicated by coronary artery disease and cerebrovascular disease.
Topics: Adult; Anticholesteremic Agents; Cerebrovascular Disorders; Cholesterol, LDL; Computed Tomography Angiography; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Echocardiography; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Infant, Newborn; Magnetic Resonance Angiography; Magnetic Resonance Imaging, Cine; Pregnancy; Pregnancy Complications, Cardiovascular | 2018 |